Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy

Modeled results demonstrate that ready-to-dilute Tepylute® may save time, reduce acquisition and preparation costs, and lower clinical risks from preparation errors, among the first to quantify potential savings from switching to a ready-to-dilute formulation.